{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:13:40Z","timestamp":1788304420248,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ajic.2023.09.005","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T15:05:48Z","timestamp":1694963148000},"page":"293-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trends and patterns of antibiotics use in Serbia from 2006 to 2021: Pre-COVID-19 period versus COVID-19 pandemic"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-2394","authenticated-orcid":false,"given":"Jelena","family":"Filimonovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorica Stanojevi\u0107","family":"Risti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9621-8375","authenticated-orcid":false,"given":"Tatjana","family":"Gazibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladan","family":"Saponjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Dotlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verica","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Arsovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Vukajlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-2539","authenticated-orcid":false,"given":"Bojan","family":"Joksimovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-8448","authenticated-orcid":false,"given":"Dragana","family":"Sokolovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-4352","authenticated-orcid":false,"given":"Dragana","family":"Drakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Dimitrijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Plavsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Milic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2023.09.005_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/antibiotics8020045","article-title":"Antibiotic discovery: where have we come from, where do we go?","volume":"8","author":"Ribeiro da Cunha","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S2542-5196(21)00280-1","article-title":"Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study","volume":"5","author":"Browne","year":"2021","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.ajic.2023.09.005_bib3","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU\/EEA (ESAC-Net)\u2014Annual Epidemiological Report 2021. Stockholm: ECDC; 2022. Accessed December 20, 2022. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-consumption-europe-2021."},{"key":"10.1016\/j.ajic.2023.09.005_bib4","first-page":"2221","article-title":"Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"GBD 2019","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2023.09.005_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jgar.2020.10.009","article-title":"Antibiotic resistance surveillance systems: a review","volume":"23","author":"Diallo","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ajic.2023.09.005_bib6","first-page":"71","article-title":"Antimicrobial resistance in the context of the sustainable development goals: a brief review","volume":"11","author":"Gajdacs","year":"2021","journal-title":"Eur J Investig Health Psychol Educ"},{"key":"10.1016\/j.ajic.2023.09.005_bib7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/antibiotics11101325","article-title":"Knowledge, attitudes and practices of parents and pediatricians regarding antibiotic use among children: differences in relation to the level of education of the parents in the Republic of Srpska Bosnia and Herzegovina","volume":"11","author":"Mijovic","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib8","article-title":"Trends in hospital antibiotic utilization during the coronavirus disease 2019 (COVID-19) pandemic: a multicenter interrupted time-series analysis","volume":"2","author":"Elligsen","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.ajic.2023.09.005_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.31083\/j.rcm.2020.04.260","article-title":"Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection","volume":"21","author":"Procter","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.ajic.2023.09.005_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13785","article-title":"Azithromycin and COVID-19: prompt early use at first signs of this infection in adults and children, an approach worthy of consideration","volume":"33","author":"Schwartz","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ajic.2023.09.005_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-020-00900-w","article-title":"Italian SITIP-SIP SARS-Cov-2 pediatric infection study group. Treatment of children with COVID-19: position paper of the Italian Society of Pediatric Infectious Disease","volume":"46","author":"Venturini","year":"2020","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.ajic.2023.09.005_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics11070847","article-title":"Antibiotic (Mis) use in COVID-19 patients before and after admission to a tertiary hospital in Serbia","volume":"11","author":"Despotovic","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph192315590","article-title":"Factors associated with the antibiotic treatment of children hospitalized for COVID-19 during the lockdown in Serbia","volume":"19","author":"Prijic","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ajic.2023.09.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph16010027","article-title":"Drivers of irrational use of antibiotics in Europe","volume":"16","author":"Machowska","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ajic.2023.09.005_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cmi.2019.08.007","article-title":"How to start an antimicrobial stewardship programme in a hospital","volume":"26","author":"Mendelson","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2023.09.005_bib16","unstructured":"Medicines and Medical Devices Agency of Serbia (ALIMS). Trade and consumption of medicines for human use in Republic of Serbia in 2020. https:\/\/www.alims.gov.rs\/wp-content\/uploads\/2022\/08\/PROMET-HUMANIH-2020-PUBLIKACIJA-1.pdf [in Serbian]. Accessed April 2, 2023."},{"key":"10.1016\/j.ajic.2023.09.005_bib17","unstructured":"World Health Organization (WHO). ATC\/DDD Index. 2022. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed April 2, 2023."},{"key":"10.1016\/j.ajic.2023.09.005_bib18","unstructured":"World Health Organization. Definition and general considerations. WHO Collaborating Centre for Drug Statistics Methodology. https:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/. Accessed April 2, 2023."},{"key":"10.1016\/j.ajic.2023.09.005_bib19","unstructured":"National Cancer Institute. Jointpoint trend analysis software. Accessed December 20, 2022. https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"key":"10.1016\/j.ajic.2023.09.005_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"21st WHO expert committee on selection and use of essential medicines. Classifying antibiotics in the WHO essential medicines list for optimal use-be AWaRe","volume":"18","author":"Sharland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2023.09.005_bib21","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU\/EEA (ESAC-Net)\u2014Annual Epidemiological Report 2021. Stockholm: ECDC; 2022."},{"key":"10.1016\/j.ajic.2023.09.005_bib22","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3855\/jidc.17148","article-title":"Antibiotic consumption in hospitals during COVID-19 pandemic: a comparative study","volume":"16","author":"Hussein","year":"2022","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.ajic.2023.09.005_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11096-017-0461-3","article-title":"Self-medication with antibiotics in Serbian households: a case for action?","volume":"39","author":"Tomas","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.ajic.2023.09.005_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/antibiotics10040397","article-title":"Increase and change in the pattern of antibiotic use in Serbia (2010-2019)","volume":"10","author":"Tomas","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/M20-2189","article-title":"Treatment of community-acquired pneumonia during the coronavirus disease (COVID-19) pandemic","volume":"173","author":"Metlay","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajic.2023.09.005_bib26","unstructured":"FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. U.S. Food and Drugs Administration. 2018. Accessed March 28, 2023. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics."},{"key":"10.1016\/j.ajic.2023.09.005_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/DHPS.S226505","article-title":"Assessment of the appropriateness of ceftazidime use in a tertiary teaching hospital, Northern Ethiopia","volume":"11","author":"Gebremichael","year":"2019","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.ajic.2023.09.005_bib28","series-title":"WHO Releases the 2019 AWaRe Classification Antibiotics","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.ajic.2023.09.005_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics11080991","article-title":"Antibiotic use and bacterial infection in COVID-19 patients in the second phase of the SARS-CoV-2 pandemic: a scoping review","volume":"11","author":"Cong","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/23744235.2021.1963471","article-title":"Carbapenemase-producing Enterobacterales infections in COVID-19 patients","volume":"54","author":"Pintado","year":"2022","journal-title":"Infect Dis"},{"key":"10.1016\/j.ajic.2023.09.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.00648","article-title":"The rapid emergence of tigecycline resistance in blaKPC-2 harboring klebsiella pneumoniae, as mediateD IN VIVO BY MUTATion in tetA during tigecycline treatment","volume":"9","author":"Du","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ajic.2023.09.005_bib32","unstructured":"European Centre for Disease Prevention and Control & World Health Organization. Regional Office for Europe. Antimicrobial Resistance Surveillance in Europe 2022\u20132020 Data; World Health Organization. Regional Office for Europe: Geneva, Switzerland; 2022."},{"key":"10.1016\/j.ajic.2023.09.005_bib33","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.transproceed.2014.09.160","article-title":"Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study","volume":"46","author":"Mouloudi","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajic.2023.09.005_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2022","article-title":"New antibiotics for Gram-negative pneumonia","volume":"31","author":"Bassetti","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ajic.2023.09.005_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics11081007","article-title":"Ceftazidime\/Avibactam in ventilator-associated pneumonia due to difficult-to-treat non-fermenter gram-negative bacteria in COVID-19 patients: a case series and review of the literature","volume":"11","author":"Burastero","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib36","first-page":"1","article-title":"Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020","volume":"17","author":"Bogdanic","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajic.2023.09.005_bib37","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2298\/VSP170731153P","article-title":"Inappropriate prescribing of antibiotics to the patients with acute bronchitis","volume":"76","author":"Petrovic","year":"2019","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.ajic.2023.09.005_bib38","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1017\/S0950268814001125","article-title":"Trends in macrolide resistance of respiratory tract pathogens in the paediatric population in Serbia from 2004 to 2009","volume":"143","author":"Mijac","year":"2015","journal-title":"Epidemiol. Infect"},{"key":"10.1016\/j.ajic.2023.09.005_bib39","unstructured":"Batut, M.J. Annual Report on Communicable Diseases. 2022. Accessed May 27, 2023. https:\/\/www.batut.org.rs\/download\/izvestaji\/GodisnjiIzvestajZarazneBolestiSrbija2022.pdf."},{"key":"10.1016\/j.ajic.2023.09.005_bib40","unstructured":"Batut, M.J. Annual Report on Communicable Diseases. 2018. Accessed May 27, 2023. https:\/\/www.batut.org.rs\/download\/izvestaji\/GodisnjiIzvestajOZaraznimBolestima2018.pdf."},{"key":"10.1016\/j.ajic.2023.09.005_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics12020308","article-title":"Antibiotic utilization during COVID-19: are we over-prescribing?","volume":"12","author":"Bednarcuk","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics12050860","article-title":"Aminoglycosides for the treatment of severe infection due to resistant gram-negative pathogens","volume":"12","author":"Thy","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ajic.2023.09.005_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/20018525.2018.1529535","article-title":"Amoxicillin is associated with a lower risk of further antibiotic prescriptions for lower respiratory tract infections in primary care\u2014a database analysis spanning over 30 years","volume":"5","author":"Stolbrink","year":"2018","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.ajic.2023.09.005_bib44","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU\/EEA (ESAC-Net) - Annual Epidemiological Report 2020. Stockholm: ECDC; 2021. Accessed April 17, 2023. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-consumption-europe-2020."},{"key":"10.1016\/j.ajic.2023.09.005_bib45","unstructured":"O\u2019Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016. Accessed March 14, 2023. https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf."},{"key":"10.1016\/j.ajic.2023.09.005_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrmicro1325","article-title":"Antimicrobial-resistant bacteria in the community setting","volume":"4","author":"Furuya","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ajic.2023.09.005_bib47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323006272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655323006272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T03:09:59Z","timestamp":1725332999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655323006272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0196655323006272"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2023.09.005","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and patterns of antibiotics use in Serbia from 2006 to 2021: Pre-COVID-19 period versus COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}